All the news articles and press releases in one place.

Date / Time Source Ticker Company Sector Market Cap Announcement
09Jan20 14:30 RNS SALV:LON Salvarx Group Health £6.74m Cancellation of trading on AIM
20Dec19 10:30 RNS SALV:LON Salvarx Group Health £6.74m Cancellation of AIM listing /Potential acquisition
27Sep19 11:07 RNS SALV:LON Salvarx Group Health £6.74m Half-year Report - Correction
26Sep19 14:06 RNS SALV:LON Salvarx Group Health £6.74m Half-year Report
23Sep19 15:02 RNS SALV:LON Salvarx Group Health £6.74m AIM Rule 17 Notification
09Jul19 07:30 RNS SALV:LON Salvarx Group Health £6.74m Suspension of Trading
09Jul19 07:30 RNS SALV:LON Salvarx Group Health £6.74m Suspension - SalvaRx Group Plc
28Jun19 11:26 RNS SALV:LON Salvarx Group Health £6.74m Final Results
31Jan19 07:00 RNS SALV:LON Salvarx Group Health £6.74m Change of Nominated Adviser and Broker
08Jan19 16:15 RNS SALV:LON Salvarx Group Health £6.74m Result of AGM and Completion of Disposal
04Jan19 17:30 RNS SALV:LON Salvarx Group Health £6.74m Salvarx Group
14Dec18 07:50 RNS SALV:LON Salvarx Group Health £6.74m Nominated Adviser Status
10Dec18 07:00 RNS SALV:LON Salvarx Group Health £6.74m Issue of US$1 million of Loan Notes by iOx
27Nov18 07:00 RNS SALV:LON Salvarx Group Health £6.74m Posting of Circular and Notice of AGM
21Nov18 13:00 RNS SALV:LON Salvarx Group Health £6.74m Transaction Update
06Nov18 07:00 RNS SALV:LON Salvarx Group Health £6.74m Director/PDMR Dealing
22Oct18 09:47 RNS SALV:LON Salvarx Group Health £6.74m Intensity Therapeutics Update
09Oct18 07:00 RNS SALV:LON Salvarx Group Health £6.74m Exercise of Warrants
28Aug18 17:40 RNS SALV:LON Salvarx Group Health £6.74m Update re proposed disposal and demerger
14Aug18 07:00 RNS SALV:LON Salvarx Group Health £6.74m Proposed disposal of interest in SalvaRx Limited
23Jul18 13:17 RNS SALV:LON Salvarx Group Health £6.74m Delay in iOx development programme
28Jun18 07:00 RNS SALV:LON Salvarx Group Health £6.74m Final Results
26Jun18 07:00 RNS SALV:LON Salvarx Group Health £6.74m Related Party Loan of US$1 million
08Mar18 12:00 RNS SALV:LON Salvarx Group Health £6.74m Drug Pipeline Progress and iOx Loan Note Issue
23Oct17 07:00 RNS SALV:LON Salvarx Group Health £6.74m Subscriptions for SalvaRx Ltd Loan Facility
27Sep17 09:00 RNS SALV:LON Salvarx Group Health £6.74m Half-year Report
25Sep17 08:00 RNS SALV:LON Salvarx Group Health £6.74m Formation of Saugatuck Therapeutics
31Jul17 13:45 RNS SALV:LON Salvarx Group Health £6.74m Result of AGM
05Jul17 15:03 RNS SALV:LON Salvarx Group Health £6.74m Notice of AGM
30Jun17 08:34 RNS SALV:LON Salvarx Group Health £6.74m Final Results
30May17 12:45 RNS SALV:LON Salvarx Group Health £6.74m Intensity Therapeutics Treats First Patient
20Mar17 07:00 RNS SALV:LON Salvarx Group Health £6.74m Investment in Rift Biotherapeutics
02Mar17 07:00 RNS SALV:LON Salvarx Group Health £6.74m Restructuring, Loan Conversion and Loan Facility
28Feb17 07:00 RNS SALV:LON Salvarx Group Health £6.74m Investment in Nekonal
02Feb17 16:37 RNS SALV:LON Salvarx Group Health £6.74m Intensity Therapeutics
13Sep16 07:00 RNS SALV:LON Salvarx Group Health £6.74m Half-year Report
22Aug16 07:00 RNS SALV:LON Salvarx Group Health £6.74m Drug Pipeline Progress including Patent Grants
04Aug16 14:05 RNS SALV:LON Salvarx Group Health £6.74m Result of AGM
27Jun16 07:00 RNS SALV:LON Salvarx Group Health £6.74m Final Results
22Apr16 07:00 RNS SALV:LON Salvarx Group Health £6.74m Investment in Intensity Therapeutics Inc
22Mar16 07:00 RNS SALV:LON Salvarx Group Health £6.74m First Day of Dealings
21Mar16 12:38 RNS SALV:LON Salvarx Group Health £6.74m Result of General Meeting
11Mar16 09:19 RNS SALV:LON Salvarx Group Health £6.74m Schedule 1 update - 3Legs Resources plc
03Mar16 07:00 RNS SALV:LON Salvarx Group Health £6.74m Schedule 1 - 3Legs Resources plc
03Mar16 07:00 RNS SALV:LON Salvarx Group Health £6.74m Reverse Takeover and Placing
04Nov15 07:35 RNS SALV:LON Salvarx Group Health £6.74m Statement re. Suspension
04Nov15 07:30 RNS SALV:LON Salvarx Group Health £6.74m Suspension - 3Legs Resoures plc
Date / Time Source Company % Chg
09Jan20 14:30 RNS Salvarx Group -8.60%
Cancellation of trading on AIM
20Dec19 10:30 RNS Salvarx Group -8.60%
Cancellation of AIM listing /Potential acquisition
27Sep19 11:07 RNS Salvarx Group -8.60%
Half-year Report - Correction
26Sep19 14:06 RNS Salvarx Group -8.60%
Half-year Report
23Sep19 15:02 RNS Salvarx Group -8.60%
AIM Rule 17 Notification
09Jul19 07:30 RNS Salvarx Group -8.60%
Suspension of Trading
09Jul19 07:30 RNS Salvarx Group -8.60%
Suspension - SalvaRx Group Plc
28Jun19 11:26 RNS Salvarx Group -8.60%
Final Results
31Jan19 07:00 RNS Salvarx Group -8.60%
Change of Nominated Adviser and Broker
08Jan19 16:15 RNS Salvarx Group -8.60%
Result of AGM and Completion of Disposal
04Jan19 17:30 RNS Salvarx Group -8.60%
Salvarx Group
14Dec18 07:50 RNS Salvarx Group -8.60%
Nominated Adviser Status
10Dec18 07:00 RNS Salvarx Group -8.60%
Issue of US$1 million of Loan Notes by iOx
27Nov18 07:00 RNS Salvarx Group -8.60%
Posting of Circular and Notice of AGM
21Nov18 13:00 RNS Salvarx Group -8.60%
Transaction Update
06Nov18 07:00 RNS Salvarx Group -8.60%
Director/PDMR Dealing
22Oct18 09:47 RNS Salvarx Group -8.60%
Intensity Therapeutics Update
09Oct18 07:00 RNS Salvarx Group -8.60%
Exercise of Warrants
28Aug18 17:40 RNS Salvarx Group -8.60%
Update re proposed disposal and demerger
14Aug18 07:00 RNS Salvarx Group -8.60%
Proposed disposal of interest in SalvaRx Limited
23Jul18 13:17 RNS Salvarx Group -8.60%
Delay in iOx development programme
28Jun18 07:00 RNS Salvarx Group -8.60%
Final Results
26Jun18 07:00 RNS Salvarx Group -8.60%
Related Party Loan of US$1 million
08Mar18 12:00 RNS Salvarx Group -8.60%
Drug Pipeline Progress and iOx Loan Note Issue
23Oct17 07:00 RNS Salvarx Group -8.60%
Subscriptions for SalvaRx Ltd Loan Facility
27Sep17 09:00 RNS Salvarx Group -8.60%
Half-year Report
25Sep17 08:00 RNS Salvarx Group -8.60%
Formation of Saugatuck Therapeutics
31Jul17 13:45 RNS Salvarx Group -8.60%
Result of AGM
05Jul17 15:03 RNS Salvarx Group -8.60%
Notice of AGM
30Jun17 08:34 RNS Salvarx Group -8.60%
Final Results
30May17 12:45 RNS Salvarx Group -8.60%
Intensity Therapeutics Treats First Patient
20Mar17 07:00 RNS Salvarx Group -8.60%
Investment in Rift Biotherapeutics
02Mar17 07:00 RNS Salvarx Group -8.60%
Restructuring, Loan Conversion and Loan Facility
28Feb17 07:00 RNS Salvarx Group -8.60%
Investment in Nekonal
02Feb17 16:37 RNS Salvarx Group -8.60%
Intensity Therapeutics
13Sep16 07:00 RNS Salvarx Group -8.60%
Half-year Report
22Aug16 07:00 RNS Salvarx Group -8.60%
Drug Pipeline Progress including Patent Grants
04Aug16 14:05 RNS Salvarx Group -8.60%
Result of AGM
27Jun16 07:00 RNS Salvarx Group -8.60%
Final Results
22Apr16 07:00 RNS Salvarx Group -8.60%
Investment in Intensity Therapeutics Inc
22Mar16 07:00 RNS Salvarx Group -8.60%
First Day of Dealings
21Mar16 12:38 RNS Salvarx Group -8.60%
Result of General Meeting
11Mar16 09:19 RNS Salvarx Group -8.60%
Schedule 1 update - 3Legs Resources plc
03Mar16 07:00 RNS Salvarx Group -8.60%
Schedule 1 - 3Legs Resources plc
03Mar16 07:00 RNS Salvarx Group -8.60%
Reverse Takeover and Placing
04Nov15 07:35 RNS Salvarx Group -8.60%
Statement re. Suspension
04Nov15 07:30 RNS Salvarx Group -8.60%
Suspension - 3Legs Resoures plc
Date / Time Company % Chg
09Jan20 14:30 Salvarx Group -8.60%
Cancellation of trading on AIM
20Dec19 10:30 Salvarx Group -8.60%
Cancellation of AIM listing /Potential acquisition
27Sep19 11:07 Salvarx Group -8.60%
Half-year Report - Correction
26Sep19 14:06 Salvarx Group -8.60%
Half-year Report
23Sep19 15:02 Salvarx Group -8.60%
AIM Rule 17 Notification
09Jul19 07:30 Salvarx Group -8.60%
Suspension of Trading
09Jul19 07:30 Salvarx Group -8.60%
Suspension - SalvaRx Group Plc
28Jun19 11:26 Salvarx Group -8.60%
Final Results
31Jan19 07:00 Salvarx Group -8.60%
Change of Nominated Adviser and Broker
08Jan19 16:15 Salvarx Group -8.60%
Result of AGM and Completion of Disposal
04Jan19 17:30 Salvarx Group -8.60%
Salvarx Group
14Dec18 07:50 Salvarx Group -8.60%
Nominated Adviser Status
10Dec18 07:00 Salvarx Group -8.60%
Issue of US$1 million of Loan Notes by iOx
27Nov18 07:00 Salvarx Group -8.60%
Posting of Circular and Notice of AGM
21Nov18 13:00 Salvarx Group -8.60%
Transaction Update
06Nov18 07:00 Salvarx Group -8.60%
Director/PDMR Dealing
22Oct18 09:47 Salvarx Group -8.60%
Intensity Therapeutics Update
09Oct18 07:00 Salvarx Group -8.60%
Exercise of Warrants
28Aug18 17:40 Salvarx Group -8.60%
Update re proposed disposal and demerger
14Aug18 07:00 Salvarx Group -8.60%
Proposed disposal of interest in SalvaRx Limited
23Jul18 13:17 Salvarx Group -8.60%
Delay in iOx development programme
28Jun18 07:00 Salvarx Group -8.60%
Final Results
26Jun18 07:00 Salvarx Group -8.60%
Related Party Loan of US$1 million
08Mar18 12:00 Salvarx Group -8.60%
Drug Pipeline Progress and iOx Loan Note Issue
23Oct17 07:00 Salvarx Group -8.60%
Subscriptions for SalvaRx Ltd Loan Facility
27Sep17 09:00 Salvarx Group -8.60%
Half-year Report
25Sep17 08:00 Salvarx Group -8.60%
Formation of Saugatuck Therapeutics
31Jul17 13:45 Salvarx Group -8.60%
Result of AGM
05Jul17 15:03 Salvarx Group -8.60%
Notice of AGM
30Jun17 08:34 Salvarx Group -8.60%
Final Results
30May17 12:45 Salvarx Group -8.60%
Intensity Therapeutics Treats First Patient
20Mar17 07:00 Salvarx Group -8.60%
Investment in Rift Biotherapeutics
02Mar17 07:00 Salvarx Group -8.60%
Restructuring, Loan Conversion and Loan Facility
28Feb17 07:00 Salvarx Group -8.60%
Investment in Nekonal
02Feb17 16:37 Salvarx Group -8.60%
Intensity Therapeutics
13Sep16 07:00 Salvarx Group -8.60%
Half-year Report
22Aug16 07:00 Salvarx Group -8.60%
Drug Pipeline Progress including Patent Grants
04Aug16 14:05 Salvarx Group -8.60%
Result of AGM
27Jun16 07:00 Salvarx Group -8.60%
Final Results
22Apr16 07:00 Salvarx Group -8.60%
Investment in Intensity Therapeutics Inc
22Mar16 07:00 Salvarx Group -8.60%
First Day of Dealings
21Mar16 12:38 Salvarx Group -8.60%
Result of General Meeting
11Mar16 09:19 Salvarx Group -8.60%
Schedule 1 update - 3Legs Resources plc
03Mar16 07:00 Salvarx Group -8.60%
Schedule 1 - 3Legs Resources plc
03Mar16 07:00 Salvarx Group -8.60%
Reverse Takeover and Placing
04Nov15 07:35 Salvarx Group -8.60%
Statement re. Suspension
04Nov15 07:30 Salvarx Group -8.60%
Suspension - 3Legs Resoures plc

Frequently asked questions